Krebs Biochemicals & Industries Shareholding

Krebs Biochemicals & Industries Ltd Shareholding Pattern

The Krebs Biochemicals & Industries Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Krebs Biochemicals & Industries Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Krebs Biochemicals & Industries Ltd (NSE: KREBSBIO, BSE: 524518) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Krebs Biochemicals & Industries Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Krebs Biochemicals & Industries Ltd Shareholding Pattern (Latest)

The latest Krebs Biochemicals & Industries Ltd shareholding for Dec 2025 is:

• Promoters: 72.74%
• FII: 0.49%
• DII: 0%
• Public: 26.77%
• Government: 0%

Promoter holding in Krebs Biochemicals & Industries Ltd remains stable, reflecting consistent long-term commitment.

Krebs Biochemicals & Industries Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Krebs Biochemicals & Industries Ltd.

• Dec 2025: 72.74%
• Sept 2025: 72.74%
• Jun 2025: 72.74%
• Mar 2025: 72.74%
• Dec 2024: 72.74%

Promoter stake remains largely stable, showing consistent ownership structure.

Krebs Biochemicals & Industries Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Krebs Biochemicals & Industries Ltd.

• Dec 2025: 0.49%
• Sept 2025: 0.49%
• Jun 2025: 0.49%
• Mar 2025: 0.49%
• Dec 2024: 0.50%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Krebs Biochemicals & Industries Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

DII holdings remain stable, reflecting steady institutional participation.

Krebs Biochemicals & Industries Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 26.77%
• Sept 2025: 26.77%
• Jun 2025: 26.77%
• Mar 2025: 26.77%
• Dec 2024: 26.76%

Public holding remains stable with consistent retail participation.

Krebs Biochemicals & Industries Ltd Government Holding

Government holding in Krebs Biochemicals & Industries Ltd currently stands at 0%.

Krebs Biochemicals & Industries Ltd operates without significant government ownership.

Krebs Biochemicals & Industries Ltd Shareholding Analysis Summary

The Krebs Biochemicals & Industries Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Krebs Biochemicals & Industries Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Krebs Biochemicals & Industries Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.